Gebro 
Welcome,         Profile    Billing    Logout  
 1 Product   26 Diseases  1 Product   3 Trials   71 News 
2 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
piclidenoson (CF101) / Can-Fite
NCT06643260: A Phase 3 Study in Moderate-to-Severe Plaque Psoriasis With Piclidenoson to Study Safety and Efficacy

Not yet recruiting
3
705
NA
piclidenoson, Placebo
Can-Fite BioPharma
Plaque Psoriasis
12/27
06/28
2021-002009-85: Piclidenoson for Treatment of COVID-19 - A Randomized, Double-Blind, Placebo-Controlled Pilot Trial Пиклиденозон за лечение на COVID-19 – Рандомизирано, двойно-заслепено, плацебо-контролирано пилотно изпитване.

Not yet recruiting
2
100
Europe
Piclidenoson, CF101, Tablet
Can-Fite BioPharma, Ltd., CanFite BioPharma Ltd.
COVID-19 КОВИД-19, COVID-19 КОВИД-19, Diseases [C] - Virus Diseases [C02]
 
 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
piclidenoson (CF101) / Can-Fite
NCT06643260: A Phase 3 Study in Moderate-to-Severe Plaque Psoriasis With Piclidenoson to Study Safety and Efficacy

Not yet recruiting
3
705
NA
piclidenoson, Placebo
Can-Fite BioPharma
Plaque Psoriasis
12/27
06/28
2021-002009-85: Piclidenoson for Treatment of COVID-19 - A Randomized, Double-Blind, Placebo-Controlled Pilot Trial Пиклиденозон за лечение на COVID-19 – Рандомизирано, двойно-заслепено, плацебо-контролирано пилотно изпитване.

Not yet recruiting
2
100
Europe
Piclidenoson, CF101, Tablet
Can-Fite BioPharma, Ltd., CanFite BioPharma Ltd.
COVID-19 КОВИД-19, COVID-19 КОВИД-19, Diseases [C] - Virus Diseases [C02]
 
 

Download Options